Gynae oncologyFree in the app
Ovarian cancer — treatment
Complete removal of all visible disease matters most.
Source: ESGO 2023 · ESMO-ESGO 2024 · NICE TAs| Apparent early | Staging: washings, TAH, BSO, omentectomy, peritoneal biopsies, pelvic and para-aortic nodes (appendix if mucinous). |
|---|---|
| Advanced | Primary surgery aiming for no residual disease. |
| Not resectable or unfit | Biopsy, then 3–4 cycles chemo, interval surgery, then complete 6 cycles. |
| Chemotherapy | Carboplatin AUC 5–6 plus paclitaxel 175 mg/m² every 3 weeks for 6 cycles. |
| Maintenance | BRCA-mutated: olaparib 2 years. HRD-positive: olaparib plus bevacizumab. Any status: niraparib 3 years. |
| Genetics | Germline BRCA testing for all non-mucinous epithelial cancers. |
A summary for trained clinicians. Always check the full guideline, the patient in front of you and your hospital's protocol. Spotted an error? Tell us.